Cwm, LLC Argenx Se Transaction History

Cwm, LLC

$33.3 Billion
Q3 2025

A detailed history of Cwm, LLC transactions in Argenx Se stock. As of the latest transaction made, Cwm, LLC holds 361 shares of ARGX stock, worth $327,780. This represents 0.0% of its overall portfolio holdings.

Number of Shares

361

Previous 203 77.83%

Holding current value

$327,780

Previous $112,000 138.39%

% of portfolio

0.0%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	BUY	$538.64 - $768.0 $85,105 - $121,344	158 Added 77.83%	361 $267,000
Q2 2025 Jul 25, 2025	SELL	$532.27 - $656.65 $12,774 - $15,759	-24 Reduced 10.57%	203 $112,000
Q1 2025 May 01, 2025	BUY	$571.0 - $671.75 $6,852 - $8,061	12 Added 5.58%	227 $135,000
Q4 2024 Feb 04, 2025	SELL	$520.52 - $638.33 $1,561 - $1,914	-3 Reduced 1.38%	215 $132,000
Q3 2024 Oct 08, 2024	BUY	$434.22 - $551.9 $7,381 - $9,382	17 Added 8.46%	218 $118,000

Q2 2024 Jul 09, 2024	BUY	$356.01 - $451.55 $4,984 - $6,321	14 Added 7.49%	201 $86,000
Q1 2024 Apr 05, 2024	SELL	$356.95 - $413.29 $2,141 - $2,479	-6 Reduced 3.11%	187 $74,000
Q4 2023 Feb 01, 2024	SELL	$338.91 - $506.01 $4,744 - $7,084	-14 Reduced 6.76%	193 $73,000
Q3 2023 Oct 11, 2023	BUY	$369.35 - $548.43 $17,359 - $25,776	47 Added 29.38%	207 $102,000
Q2 2023 Aug 03, 2023	BUY	$360.14 - $422.58 $5,402 - $6,338	15 Added 10.34%	160 $62,000
Q1 2023 Apr 28, 2023	SELL	$334.23 - $403.65 $13,034 - $15,742	-39 Reduced 21.2%	145 $54,000
Q4 2022 Feb 01, 2023	BUY	$342.17 - $402.31 $7,527 - $8,850	22 Added 13.58%	184 $70,000
Q3 2022 Oct 27, 2022	BUY	$343.2 - $395.75 $16,473 - $18,996	48 Added 42.11%	162 $57,000
Q2 2022 Jul 28, 2022	BUY	$269.58 - $378.88 $15,905 - $22,353	59 Added 107.27%	114 $43,000
Q1 2022 Apr 21, 2022	BUY	$254.45 - $351.06 $5,597 - $7,723	22 Added 66.67%	55 $17,000
Q4 2021 Jan 31, 2022	BUY	$272.01 - $353.03 $7,344 - $9,531	27 Added 450.0%	33 $12,000
Q1 2021 Sep 15, 2021	BUY	$268.3 - $380.31 $1,609 - $2,281	6 New	6 $2,000
Q1 2021 Apr 27, 2021	SELL	$268.3 - $380.31 $1,609 - $2,281	-6 Closed	0 $0
Q4 2020 Sep 15, 2021	BUY	$248.13 - $308.36 $1,488 - $1,850	6 New	6 $2,000
Q4 2020 Jan 27, 2021	SELL	$248.13 - $308.36 $1,488 - $1,850	-6 Closed	0 $0
Q3 2020 Sep 15, 2021	BUY	$215.51 - $272.51 $1,293 - $1,635	6 New	6 $2,000
Q3 2020 Oct 19, 2020	SELL	$215.51 - $272.51 $1,293 - $1,635	-6 Closed	0 $0
Q2 2020 Sep 15, 2021	BUY	$127.44 - $232.72 $764 - $1,396	6 New	6 $2,000
Q2 2020 Jul 22, 2020	SELL	$127.44 - $232.72 $764 - $1,396	-6 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$108.83 - $165.23 $652 - $991	6 New	6 $2,000
Q1 2020 Apr 28, 2020	SELL	$108.83 - $165.23 $652 - $991	-6 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$106.59 - $164.21 $639 - $985	6 New	6 $2,000
Q4 2019 Jan 27, 2020	SELL	$106.59 - $164.21 $639 - $985	-6 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$113.31 - $150.51 $679 - $903	6 New	6 $2,000
Q3 2019 Oct 22, 2019	SELL	$113.31 - $150.51 $679 - $903	-6 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$115.0 - $141.58 $690 - $849	6 New	6 $2,000
Q2 2019 Jul 31, 2019	SELL	$115.0 - $141.58 $690 - $849	-6 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$98.85 - $134.59 $593 - $807	6 New	6 $0

Others Institutions Holding ARGX

# of Institutions

526

Shares Held

26M

Call Options Held

589K

Put Options Held

320K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $50.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account